ArticlePloS one2021

Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells.

Tomotaka Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.